Video

EMPOWER LUNG-3 Study of Chemoimmunotherapy in Advanced NSCLC

Key opinion leaders discuss data from the EMPOWER-Lung-3 study investigating the use of cemiplimab plus chemotherapy in both squamous and non-squamous NSCLC.

Video Player is loading.
Current Time 0:00
Duration 4:58
Loaded: 0%
Stream Type LIVE
Remaining Time 4:58
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected